Fund profile
Fund manager
Total assets
$1.00 bn
Liabilities
$12.25 mm
Net assets
$990.64 mm
Number of holdings
131.00
131 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals, Inc. | 79.01 mm | 194.18 k shares | 7.98 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 77.10 mm | 87.79 k shares | 7.78 | Common equity | Long | USA |
AMGN AMGEN Inc. | 74.28 mm | 257.89 k shares | 7.50 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 58.10 mm | 717.17 k shares | 5.86 | Common equity | Long | USA |
State Street Institutional US Government Money Market Fund | 46.75 mm | 46.75 mm shares | 4.72 | Short-term investment vehicle | Long | USA |
BIIB Biogen Inc | 36.64 mm | 141.61 k shares | 3.70 | Common equity | Long | USA |
AstraZeneca PLC
|
35.76 mm | 530.92 k shares | 3.61 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals Inc | 23.85 mm | 124.59 k shares | 2.41 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 19.85 mm | 34.05 k shares | 2.00 | Common equity | Long | USA |
ILMN Illumina Inc | 19.84 mm | 142.48 k shares | 2.00 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 19.16 mm | 198.76 k shares | 1.93 | Common equity | Long | USA |
MRNA Moderna Inc | 18.19 mm | 182.90 k shares | 1.84 | Common equity | Long | USA |
ABBV Abbvie Inc | 17.84 mm | 115.12 k shares | 1.80 | Common equity | Long | USA |
NEUROVANCE MILESTONE INTEREST
|
15.53 mm | 49.01 k shares | 1.57 | Common equity | Long | USA |
JNJ Johnson & Johnson | 14.64 mm | 93.40 k shares | 1.48 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 14.43 mm | 27.19 k shares | 1.46 | Common equity | Long | USA |
ARGX Argen X SE | 13.35 mm | 35.09 k shares | 1.35 | Common equity | Long | Netherlands |
UNH Unitedhealth Group Inc | 12.72 mm | 24.17 k shares | 1.28 | Common equity | Long | USA |
ABT Abbott Laboratories | 12.61 mm | 114.59 k shares | 1.27 | Common equity | Long | USA |
MRK Merck & Co Inc | 12.49 mm | 114.53 k shares | 1.26 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 11.71 mm | 92.96 k shares | 1.18 | Common equity | Long | Denmark |
ISRG Intuitive Surgical Inc | 11.66 mm | 34.57 k shares | 1.18 | Common equity | Long | USA |
EXEL Exelixis Inc | 11.53 mm | 480.72 k shares | 1.16 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 10.60 mm | 183.36 k shares | 1.07 | Common equity | Long | USA |
DHR Danaher Corp. | 10.19 mm | 44.07 k shares | 1.03 | Common equity | Long | USA |
HUM Humana Inc. | 9.79 mm | 21.37 k shares | 0.99 | Common equity | Long | USA |
IMVT Immunovant Inc | 9.23 mm | 219.15 k shares | 0.93 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 9.08 mm | 94.11 k shares | 0.92 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 8.73 mm | 18.20 mm shares | 0.88 | Preferred equity | Long | USA |
IDXX Idexx Laboratories, Inc. | 8.63 mm | 15.55 k shares | 0.87 | Common equity | Long | USA |
Roivant Sciences Ltd
|
8.39 mm | 747.28 k shares | 0.85 | Common equity | Long | Bermuda |
BBIO BridgeBio Pharma Inc | 8.38 mm | 207.59 k shares | 0.85 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 8.31 mm | 132.31 k shares | 0.84 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 8.18 mm | 34.62 k shares | 0.83 | Common equity | Long | USA |
Royalty Pharma PLC
|
7.43 mm | 264.45 k shares | 0.75 | Common equity | Long | UK |
CYTK Cytokinetics Inc | 7.17 mm | 85.85 k shares | 0.72 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 7.07 mm | 118.06 k shares | 0.71 | Common equity | Long | USA |
BNTX BioNTech SE | 7.01 mm | 66.40 k shares | 0.71 | Common equity | Long | Germany |
MOH Molina Healthcare Inc | 6.56 mm | 18.16 k shares | 0.66 | Common equity | Long | USA |
PFE Pfizer Inc. | 6.43 mm | 223.24 k shares | 0.65 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 6.39 mm | 20.19 k shares | 0.64 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 6.31 mm | 2.88 mm shares | 0.64 | Preferred equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 6.15 mm | 119.79 k shares | 0.62 | Common equity | Long | USA |
iSHARES INC | 5.93 mm | 43.63 k shares | 0.60 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 5.75 mm | 75.38 k shares | 0.58 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 5.73 mm | 43.50 k shares | 0.58 | Common equity | Long | USA |
MCK Mckesson Corporation | 5.64 mm | 12.18 k shares | 0.57 | Common equity | Long | USA |
Oculis Holding AG
|
5.27 mm | 479.41 k shares | 0.53 | Common equity | Long | Switzerland |
SPDR Series Trust | 5.09 mm | 57.00 k shares | 0.51 | Common equity | Long | USA |
Alkermes PLC
|
4.82 mm | 173.91 k shares | 0.49 | Common equity | Long | Ireland |
INVETX, INC. | 4.82 mm | 7.19 mm shares | 0.49 | Preferred equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 4.72 mm | 98.64 k shares | 0.48 | Common equity | Long | USA |
GH Guardant Health Inc | 4.70 mm | 173.67 k shares | 0.47 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 4.60 mm | 214.50 k shares | 0.46 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 4.43 mm | 87.61 k shares | 0.45 | Common equity | Long | USA |
HCA HCA Healthcare Inc | 4.39 mm | 16.23 k shares | 0.44 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 4.37 mm | 21.49 k shares | 0.44 | Common equity | Long | USA |
Medtronic PLC
|
4.32 mm | 52.38 k shares | 0.44 | Common equity | Long | Ireland |
MRNS Marinus Pharmaceuticals Inc | 4.19 mm | 385.15 k shares | 0.42 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 3.92 mm | 17.84 k shares | 0.40 | Common equity | Long | USA |
SYK Stryker Corp. | 3.86 mm | 12.89 k shares | 0.39 | Common equity | Long | USA |
AMOLYT PHARMA SAS | 3.79 mm | 1.60 mm shares | 0.38 | Preferred equity | Long | France |
MEDP Medpace Holdings Inc | 3.74 mm | 12.20 k shares | 0.38 | Common equity | Long | USA |
Incendia Therapeutics, Inc. | 3.40 mm | 1.77 mm shares | 0.34 | Preferred equity | Long | USA |
THC Tenet Healthcare Corp. | 3.31 mm | 43.85 k shares | 0.33 | Common equity | Long | USA |
QUELL THERAPEUTICS | 3.23 mm | 1.55 mm shares | 0.33 | Preferred equity | Long | USA |
NTLA Intellia Therapeutics Inc | 3.16 mm | 103.66 k shares | 0.32 | Common equity | Long | USA |
ENDEAVOR BIOMEDICINES, INC. | 3.10 mm | 657.32 k shares | 0.31 | Preferred equity | Long | USA |
TEVA Teva- Pharmaceutical Industries Ltd. | 3.04 mm | 291.67 k shares | 0.31 | Common equity | Long | Israel |
AVTR Avantor Inc. | 2.96 mm | 129.49 k shares | 0.30 | Common equity | Long | USA |
RECODE THERAPEUTICS | 2.95 mm | 319.14 k shares | 0.30 | Preferred equity | Long | USA |
ZBH Zimmer Biomet Holdings Inc | 2.94 mm | 24.14 k shares | 0.30 | Common equity | Long | USA |
ABCURO, INC. | 2.93 mm | 532.82 k shares | 0.30 | Preferred equity | Long | USA |
ADPT Adaptive Biotechnologies Corp | 2.89 mm | 589.29 k shares | 0.29 | Common equity | Long | USA |
Jazz Pharmaceuticals PLC
|
2.72 mm | 22.12 k shares | 0.27 | Common equity | Long | Ireland |
PODD Insulet Corporation | 2.51 mm | 11.57 k shares | 0.25 | Common equity | Long | USA |
MREO Mereo Biopharma Group Plc | 2.46 mm | 1.06 mm shares | 0.25 | Common equity | Long | UK |
INSM Insmed Inc | 2.16 mm | 69.82 k shares | 0.22 | Common equity | Long | USA |
INVETX, INC. | 2.07 mm | 3.09 mm shares | 0.21 | Preferred equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 2.01 mm | 136.50 k shares | 0.20 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 1.93 mm | 5.47 k shares | 0.19 | Common equity | Long | USA |
CTLT Catalent Inc. | 1.91 mm | 42.40 k shares | 0.19 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 1.81 mm | 302.04 k shares | 0.18 | Common equity | Long | USA |
RLYB Rallybio Corp | 1.80 mm | 755.08 k shares | 0.18 | Common equity | Long | USA |
DXCM Dexcom Inc | 1.77 mm | 14.30 k shares | 0.18 | Common equity | Long | USA |
XNCR Xencor Inc | 1.66 mm | 78.14 k shares | 0.17 | Common equity | Long | USA |
uniQure NV
|
1.65 mm | 244.09 k shares | 0.17 | Common equity | Long | Netherlands |
Dynacure SA | 1.64 mm | 243.46 k shares | 0.17 | Preferred equity | Long | France |
Impact Biomedicines Milestone Preferred Stock | 1.55 mm | 78.18 k shares | 0.16 | Preferred equity | Long | USA |
BAX Baxter International Inc. | 1.53 mm | 39.60 k shares | 0.15 | Common equity | Long | USA |
BIOTHERYX, INC. SERIES E | 1.50 mm | 1.30 mm shares | 0.15 | Preferred equity | Long | USA |
A Agilent Technologies Inc. | 1.44 mm | 10.34 k shares | 0.15 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 1.39 mm | 632.39 k shares | 0.14 | Preferred equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 1.38 mm | 19.22 k shares | 0.14 | Common equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 1.36 mm | 82.08 k shares | 0.14 | Preferred equity | Long | USA |
PRIOTHERA LIMITED | 1.34 mm | 346.67 k shares | 0.14 | Preferred equity | Long | Ireland |
HIBERCELL, INC. SERIES B | 1.29 mm | 2.77 mm shares | 0.13 | Preferred equity | Long | USA |
SRRK Scholar Rock Holding Corp | 1.28 mm | 68.12 k shares | 0.13 | Common equity | Long | USA |
ARKUDA THERAPEUTICS, INC. | 1.14 mm | 1.04 mm shares | 0.12 | Preferred equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 1.09 mm | 5.55 k shares | 0.11 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 935.17 k | 40.05 k shares | 0.09 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 910.75 k | 42.03 k shares | 0.09 | Common equity | Long | USA |
PYXS Pyxis Oncology Inc | 866.96 k | 481.65 k shares | 0.09 | Common equity | Long | USA |
OCULIS HOLDING AG
|
863.94 k | 78.54 k shares | 0.09 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 854.87 k | 3.51 k shares | 0.09 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 846.39 k | 846.39 k principal | 0.09 | Debt | Long | USA |
TCRX Tscan Therapeutics Inc | 804.87 k | 138.06 k shares | 0.08 | Common equity | Long | USA |
HIBERCELL,INC. SERIES C | 708.97 k | 1.53 mm shares | 0.07 | Preferred equity | Long | USA |
ETNB 89bio Inc | 630.97 k | 56.49 k shares | 0.06 | Common equity | Long | USA |
GTHX G1 Therapeutics Inc | 611.50 k | 200.49 k shares | 0.06 | Common equity | Long | USA |
IO LIGHT HOLDINIGS, INC. | 453.59 k | 421.63 k shares | 0.05 | Preferred equity | Long | USA |
STRO Sutro Biopharma Inc | 297.68 k | 69.39 k shares | 0.03 | Common equity | Long | USA |
AFFERENT MILESTONE INTEREST
|
284.62 k | 26.21 k shares | 0.03 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics Inc | 280.59 k | 86.87 k shares | 0.03 | Common equity | Long | USA |
NVAX Novavax, Inc. | 178.50 k | 37.19 k shares | 0.02 | Common equity | Long | USA |
CERCACOR LABORATORIES INC
|
172.18 k | 160.00 k shares | 0.02 | Common equity | Long | USA |
CONTRA CHINOOK THERAPE | 150.55 k | 91.80 k shares | 0.02 | Equity derivative | N/A | USA |
Mural Oncology PLC
|
102.95 k | 17.39 k shares | 0.01 | Common equity | Long | Ireland |
IMAB I-Mab | 102.38 k | 53.89 k shares | 0.01 | Common equity | Long | Cayman Islands |
PRAX Praxis Precision Medicines Inc | 76.35 k | 3.43 k shares | 0.01 | Common equity | Long | USA |
FUSION PHARMACEUTICALS, INC.
|
65.67 k | 7.59 k shares | 0.01 | Common equity | Long | USA |
GRTX Galera Therapeutics Inc | 43.11 k | 296.46 k shares | 0.00 | Common equity | Long | USA |
INNOVACARE INC
|
28.80 k | 222.22 k shares | 0.00 | Common equity | Long | USA |
TETRAPHASE PHARMACEUTICALS INC | 1.72 k | 28.75 k shares | 0.00 | Equity derivative | N/A | USA |
ARKUDA THERAPEUTICS,INC SER A. | 235.39 | 2.35 mm shares | 0.00 | Preferred equity | Long | USA |
Endo International PLC
|
232.75 | 465.51 k shares | 0.00 | Common equity | Long | Ireland |
HIBERCELL, INC. SERIES C | 1.53 | 1.53 mm shares | 0.00 | Equity derivative | N/A | USA |
CONTRA SPECTRUM PHARMA | 0.08 | 79.79 k shares | 0.00 | Equity derivative | N/A | USA |
RAINIER THERAPEUTICS, INC. | 0 | 3.95 k shares | 0.00 | Preferred equity | Long | USA |
ETHISMOS RESEARCH, INC. MILEST | 0 | 1.18 k shares | 0.00 | Preferred equity | Long | USA |
AMPHIVENA MILESTONE INTEREST | 0 | 100.00 shares | 0.00 | Preferred equity | Long | USA |